Cme (CME) Gains from Investment Securities (2010 - 2026)

Cme (CME) has 17 years of Gains from Investment Securities data on file, last reported at $22.0 million in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $22.0 million, up 168.29% year-over-year; the trailing twelve-month figure through Mar 2026 was -$24.6 million (down 185.12% YoY), and the FY2025 annual result was -$38.4 million, down 216.36% from the prior year.
• Gains from Investment Securities advanced to $22.0 million in Q1 2026 per CME's latest filing, from -$41.8 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $43.2 million in Q4 2023 and troughed at -$42.4 million in Q4 2022.
• A 5-year average of -$206250.0 and a median of $350000.0 in 2024 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2022 and 2023: Gains from Investment Securities plunged 1042.22% in 2022, then surged 671.88% in 2023.
• A 5-year view of Gains from Investment Securities shows it stood at -$42.4 million in 2022, then surged by 201.89% to $43.2 million in 2023, then slumped by 31.94% to $29.4 million in 2024, then plunged by 242.18% to -$41.8 million in 2025, then jumped by 152.63% to $22.0 million in 2026.
• Business Quant data shows CME's Gains from Investment Securities at $22.0 million in Q1 2026, -$41.8 million in Q4 2025, and -$5.4 million in Q3 2025.